Antitumor vascular strategy for controlling experimental metastatic spread of human small-cell lung cancer cells with ZD6474 in natural killer cell-depleted severe combined immunodeficient mice. [electronic resource]
Producer: 20060120Description: 8789-98 p. digitalISSN:- 1078-0432
- Angiogenesis Inhibitors -- pharmacology
- Animals
- Antineoplastic Agents -- therapeutic use
- Carcinoma, Small Cell -- drug therapy
- Cell Line, Tumor
- Cell Proliferation -- drug effects
- Endothelium, Vascular -- drug effects
- Humans
- Killer Cells, Natural -- immunology
- Lung Neoplasms -- drug therapy
- Lymphocyte Depletion
- Mice
- Mice, SCID
- Neovascularization, Pathologic -- drug therapy
- Piperidines -- pharmacology
- Quinazolines -- pharmacology
- RNA, Messenger -- analysis
- Vascular Endothelial Growth Factor A -- analysis
- Vascular Endothelial Growth Factor Receptor-1 -- analysis
- Vascular Endothelial Growth Factor Receptor-2 -- analysis
- Vascular Endothelial Growth Factor Receptor-3 -- analysis
- Xenograft Model Antitumor Assays
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.